PL2151429T3 - Nowy sposób syntezy agomelatyny - Google Patents

Nowy sposób syntezy agomelatyny

Info

Publication number
PL2151429T3
PL2151429T3 PL09290607T PL09290607T PL2151429T3 PL 2151429 T3 PL2151429 T3 PL 2151429T3 PL 09290607 T PL09290607 T PL 09290607T PL 09290607 T PL09290607 T PL 09290607T PL 2151429 T3 PL2151429 T3 PL 2151429T3
Authority
PL
Poland
Prior art keywords
agomelatin
preparation
Prior art date
Application number
PL09290607T
Other languages
English (en)
Inventor
Christophe Hardouin
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2151429T3 publication Critical patent/PL2151429T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL09290607T 2008-08-05 2009-08-04 Nowy sposób syntezy agomelatyny PL2151429T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine
EP09290607A EP2151429B1 (fr) 2008-08-05 2009-08-04 Nouveau procédé de synthèse de l'agomélatine

Publications (1)

Publication Number Publication Date
PL2151429T3 true PL2151429T3 (pl) 2011-11-30

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09290607T PL2151429T3 (pl) 2008-08-05 2009-08-04 Nowy sposób syntezy agomelatyny

Country Status (46)

Country Link
US (1) US8143449B2 (pl)
EP (1) EP2151429B1 (pl)
JP (1) JP5021004B2 (pl)
KR (1) KR101127357B1 (pl)
CN (1) CN101643431B (pl)
AP (1) AP2509A (pl)
AR (1) AR074887A1 (pl)
AT (1) ATE510816T1 (pl)
AU (1) AU2009202905B2 (pl)
BR (1) BRPI0903045A2 (pl)
CA (1) CA2674764C (pl)
CL (1) CL2009001632A1 (pl)
CR (1) CR10934A (pl)
CU (1) CU23858B1 (pl)
CY (1) CY1111573T1 (pl)
DK (1) DK2151429T3 (pl)
EA (1) EA017684B1 (pl)
EC (1) ECSP099549A (pl)
ES (1) ES2367236T3 (pl)
FR (1) FR2934855B1 (pl)
GE (1) GEP20115344B (pl)
GT (1) GT200900218A (pl)
HK (1) HK1141004A1 (pl)
HN (1) HN2009001435A (pl)
HR (1) HRP20110568T1 (pl)
IL (1) IL199875A (pl)
JO (1) JO2821B1 (pl)
MA (1) MA31830B1 (pl)
ME (1) ME00927B (pl)
MX (1) MX2009007971A (pl)
MY (1) MY144746A (pl)
NI (1) NI200900152A (pl)
NZ (1) NZ578381A (pl)
PE (1) PE20100259A1 (pl)
PL (1) PL2151429T3 (pl)
PT (1) PT2151429E (pl)
RS (1) RS51740B (pl)
SA (1) SA109300498B1 (pl)
SG (1) SG158814A1 (pl)
SI (1) SI2151429T1 (pl)
SV (1) SV2009003344A (pl)
TW (1) TWI376365B (pl)
UA (1) UA106195C2 (pl)
UY (1) UY31985A (pl)
WO (1) WO2010015746A1 (pl)
ZA (1) ZA200905051B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2580183B1 (en) 2010-06-10 2014-07-23 Gador S.A. New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69516156T2 (de) * 1994-09-06 2000-09-21 Shionogi & Co., Ltd. Verfahren zur herstellung von alkoxyimino acetamid-derivaten
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
GT200900218A (es) 2010-08-23
RS51740B (en) 2011-10-31
ME00927B (me) 2012-06-20
EA200900943A1 (ru) 2010-04-30
UY31985A (es) 2010-01-29
MX2009007971A (es) 2010-03-25
JP2010043078A (ja) 2010-02-25
MA31830B1 (fr) 2010-11-01
BRPI0903045A2 (pt) 2010-05-25
CU20090131A7 (es) 2011-05-27
FR2934855A1 (fr) 2010-02-12
HN2009001435A (es) 2011-12-27
JP5021004B2 (ja) 2012-09-05
DK2151429T3 (da) 2011-09-19
CR10934A (es) 2009-10-15
UA106195C2 (ru) 2014-08-11
CY1111573T1 (el) 2015-10-07
SI2151429T1 (sl) 2011-09-30
CU23858B1 (es) 2013-02-26
KR101127357B1 (ko) 2012-04-12
IL199875A0 (en) 2010-05-17
AP2009004929A0 (en) 2009-08-31
PT2151429E (pt) 2011-07-11
TW201018658A (en) 2010-05-16
SA109300498B1 (ar) 2013-07-23
SV2009003344A (es) 2010-02-05
US8143449B2 (en) 2012-03-27
IL199875A (en) 2013-10-31
NI200900152A (es) 2010-03-25
US20100036163A1 (en) 2010-02-11
CA2674764C (fr) 2012-04-17
KR20100017060A (ko) 2010-02-16
SG158814A1 (en) 2010-02-26
HK1141004A1 (en) 2010-10-29
ECSP099549A (es) 2010-03-31
TWI376365B (en) 2012-11-11
AP2509A (en) 2012-11-19
GEP20115344B (en) 2011-12-12
ES2367236T3 (es) 2011-10-31
CL2009001632A1 (es) 2010-07-19
EA017684B1 (ru) 2013-02-28
HRP20110568T1 (en) 2011-09-30
ATE510816T1 (de) 2011-06-15
FR2934855B1 (fr) 2010-08-13
AR074887A1 (es) 2011-02-23
PE20100259A1 (es) 2010-04-10
AU2009202905B2 (en) 2013-09-05
NZ578381A (en) 2010-11-26
CN101643431A (zh) 2010-02-10
WO2010015746A1 (fr) 2010-02-11
JO2821B1 (en) 2014-09-15
CA2674764A1 (fr) 2010-02-05
MY144746A (en) 2011-10-31
CN101643431B (zh) 2013-05-15
EP2151429A1 (fr) 2010-02-10
EP2151429B1 (fr) 2011-05-25
ZA200905051B (en) 2010-05-26
AU2009202905A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
ZA200905012B (en) Process for the preparation of certain substituted sulfimines
IL211701A0 (en) Process for the preparation of bendamustine
ZA201202504B (en) Process for the preparation of calcobutrol
EP2410855A4 (en) PROCESS FOR THE PREPARATION OF ALOGLIPTIN
PL2151428T3 (pl) Nowy sposób syntezy agomelatyny
ZA200907191B (en) Process for the preparation of gefitiib
ZA201101836B (en) Process for the preparation of rufinamide
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
IL211556A0 (en) Process for the preparation of pramlintide
IL208792A0 (en) Process for the preparation of amides
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
EP2344468A4 (en) PROCESS FOR PREPARING RAMELTÉON
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
PL2151429T3 (pl) Nowy sposób syntezy agomelatyny
EG26332A (en) Process for the preparation of benzonoprons
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
IL215022A0 (en) Novel process for the preparation of enaminocarbonyl compounds
IL211382A0 (en) Process for the preparation of ethanedinitrile
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
IL213110A0 (en) Process for the preparation of tetrazine derivatives
GB0812613D0 (en) Process for the preparation of 1-deoxyidonojirimycin
IL220160A (en) A process for the preparation of defrasirox